Skip to main content

and
  1. Article

    Open Access

    Recombinant immunotoxins targeting B-cell maturation antigen are cytotoxic to myeloma cell lines and myeloma cells from patients

    T K Bera, Y Abe, T Ise, A Oberle, D Gallardo, X-f Liu, S Nagata, M Binder in Leukemia (2018)

  2. No Access

    Article

    MUC13 interaction with receptor tyrosine kinase HER2 drives pancreatic ductal adenocarcinoma progression

    Although MUC13, a transmembrane mucin, is aberrantly expressed in pancreatic ductal adenocarcinoma (PDAC) and generally correlates with increased expression of HER2, the underlying mechanism remains poorly und...

    S Khan, M Sikander, M C Ebeling, A Ganju, S Kumari, M M Yallapu, B B Hafeez in Oncogene (2017)

  3. No Access

    Article

    Elevation of soluble CD307 (IRTA2/FcRH5) protein in the blood and expression on malignant cells of patients with multiple myeloma, chronic lymphocytic leukemia, and mantle cell lymphoma

    CD307 is a differentiation antigen expressed in B-lineage cells. One soluble and two membrane-bound forms have been predicted and an enzyme-linked immunosorbent assay (ELISA) for soluble CD307 established. Our...

    T Ise, S Nagata, R J Kreitman, W H Wilson, A S Wayne, M Stetler-Stevenson in Leukemia (2007)

  4. No Access

    Article

    Direct interaction of p53 with the Y-box binding protein, YB-1: a mechanism for regulation of human gene expression

    The Y-box binding protein, YB-1, belongs to a family of multifunctional proteins which regulate gene expression on both transcriptional and translational levels. The tumor suppressor gene p53 displays growth s...

    T Okamoto, H Izumi, T Imamura, H Takano, T Ise, T Uchiumi, M Kuwano, K Kohno in Oncogene (2000)